Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Lupin

Sector: Healthcare | Industry: Drugs & Pharma
R 721.15 4.75  | 0.66% -18.68% 46.18 32,642.68
NSE Price: Oct 15, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:58 721.15 4.75 0.66% 718.00 716.40 1,438,966 711.50 - 726.90
BSE Oct 15, 2019 721.15 5.75 0.80% 719.50 715.40 74,503 699.70 - 726.55
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue17,280.6316,718.1815,804.1517,494.3314,255.54 12,770.0111,286.57
Other Income432.81364.02150.35106.51185.19 239.75116.48
Total Income17,713.4417,082.2015,954.5017,600.8414,440.73 13,009.7611,403.05
Total Expenditure14,245.9413,835.9612,656.6413,001.1910,570.19 9,150.428,283.78
Operating Profit3,467.503,246.243,297.864,599.653,870.54 3,859.343,119.27
Interest324.73307.83204.35152.5359.47 9.8126.65
PBDT3,142.772,938.413,093.514,447.123,811.07 3,849.533,092.62
Depreciation1,143.121,085.011,085.87912.23487.13 434.70260.97
PBT & Exceptional Items1,999.651,853.402,007.643,534.893,323.94 3,414.832,831.65
Exceptional Items-339.98-339.98-1,464.35-- --
Profit before Tax1,659.671,513.42543.293,534.893,323.94 3,414.832,831.65
Provision for Tax948.53901.69288.46978.511,059.34 970.40962.15
Profit after Tax711.14611.73254.832,556.382,264.60 2,444.431,869.50
Minority Interest-8.35-8.93-7.09-7.17-8.76 -41.19-33.13
Share of Associate4.053.753.528.254.90 --
Consolidated Profit706.84606.55251.262,557.462,260.74 2,403.241,836.37
 
LiabilitiesR Cr
Share Capital90.5090.5090.4290.3290.12 89.9089.68
Total Reserves13,651.7313,433.3113,275.2613,233.5010,958.87 8,728.156,815.66
Shareholder's Funds13,742.2313,742.2313,577.0613,497.5711,163.37 8,874.066,931.57
Minority Interest46.8646.8640.0834.5232.08 24.1066.94
Long Term Borrowings6,641.726,641.726,424.505,647.785,373.90 101.83150.96
Other Non Current Liabilities1,388.691,100.41882.66911.97667.66 324.32356.20
Current Liabilities6,129.876,129.875,095.556,120.595,061.17 3,729.232,629.55
Total Debt*-8,496.157,142.807,966.097,177.52 537.12653.74
Total Liabilities27,949.3727,661.0926,019.8526,212.4322,298.18 13,053.5410,135.22
 
AssetsR Cr
Net Block9,327.5111,086.7110,361.9911,032.938,716.96 4,368.193,355.60
Non Current Investments185.63185.6326.7122.0014.33 2.512.06
Other Non-Current Assets4,582.652,535.173,421.613,204.573,679.49 850.49677.11
Current Investments2,109.862,109.86234.862,114.132.02 1,655.89176.41
Cash and Bank987.20987.201,408.03698.17821.75 481.35797.50
Other Current Assets10,756.5210,756.5210,566.659,140.639,063.63 5,695.115,126.54
Net Current Assets7,723.717,723.717,113.995,832.344,826.23 4,103.123,470.90
Miscellaneous Exp. Not Written Off----- --
Total Assets27,949.3727,661.0926,019.8526,212.4322,298.18 13,053.5410,135.22
 
Cash FlowR Cr
From Operations-1,665.971,751.194,113.51-382.39 2,733.052,003.93
From Investing Activities--3,282.47469.87-2,527.44-6,961.71 -1,054.51-858.54
From Finance Activities-744.13-1,492.10433.185,836.38 -196.89-857.11
Net Inflow/Outflow--872.37728.962,019.25-1,507.72 1,481.65288.28
 
Key Ratios
Adjusted EPS (Rs)15.6213.405.5656.6350.17 53.4640.95
Adjusted Book Value (Rs)305.44298.87295.64295.04245.21 196.17154.00
Dividend per Share (Rs)-5.005.007.507.50 7.506.00
Cash Flow per Share (Rs)-36.8238.7391.09-8.49 60.8044.69
Debt to Equity0.480.630.530.600.65 0.060.09
Current Ratio2.262.262.401.951.95 2.102.32
ROCE (%)-8.483.5418.5324.38 40.3040.97
RONW (%)5.214.551.9120.9822.80 31.0930.89
Operating Margin (%)20.0719.4220.8726.2927.15 30.2227.64
Net Margin (%)4.013.581.6014.5215.68 18.7916.39
Revenue Growth (%)9.255.78-9.6622.7211.63 13.1417.06
Net Profit Growth (%)625.36140.05-90.0312.88-7.36 30.7539.47
EPS Growth (%)634.07141.19-90.1912.87-6.16 30.5539.47
Book Value Growth (%)-1.180.3120.5925.30 27.7032.86
 
Market Cues
Close Price (Rs)721.15739.60735.851,445.201,479.25 2,008.40933.15
High Price (Rs)914.90986.101,457.051,750.002,129.00 2,036.951,003.70
Low Price (Rs)646.30719.80727.101,382.601,280.00 902.60605.50
Market Cap (Rs Cr)32,642.6833,444.2833,292.6465,247.1766,700.07 90,216.9041,965.76
Price / Earnings46.1855.14132.5025.5129.50 37.5422.85
Price / Book Value2.362.472.494.906.04 10.236.08
Dividend Yield (%)0.690.680.680.520.51 0.370.64
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
3.29
Piotroski F-Score
5
Modified C-Score
1
5-Years Price to Earnings
46.18
5-Years Price to Book
2.36
Earnings Yield
EBIT / Enterprise value
5.22%
PEG
Price / Earnings to growth ratio
-2.38
Related Stocks
  Current Price   Chng %
Abbott India R10,917.90 -0.74%
Alkem Laboratories R1,915.10 -1.38%
Biocon R260.30 +2.74%
Cadila Healthcare R234.45 +0.75%
Cipla R446.55 +1.28%
Glaxosmithkline Pharma R1,433.15 +2.66%
Pfizer R3,193.15 +0.75%
Piramal Enterprises R1,375.85 -0.05%
Sanofi India R5,893.10 +0.23%
Torrent Pharmaceuticals R1,699.85 +0.11%
As on Oct 15, 15:59